FDA Inspection 1251219 — Children's National Medical Center

Children's National Medical Center — FEI 1177084

The FDA completed an inspection of Children's National Medical Center on September 27, 2024 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Washington, DC (United States)